PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Stone, John H.
TI  - Long-Term Results of the RAVE Trial
DP  - 2011  01
TA  - MD Conference Express
PG  - 15--16
VI  - 11
IP  - 13
4099  - http://mdc.sagepub.com/content/11/13/15.short
4100  - http://mdc.sagepub.com/content/11/13/15.full
AB  - This article discusses the results of the 18-month follow-up from the Rituximab in ANCA-Associated Vasculitis trial [RAVE; ISRCTN28528813; Stone JH et al. N Engl J Med 2010], which found that one course of treatment with rituximab was noninferior to standard course of therapy (cyclophosphamide followed by azathioprine) for remission-induction of severe antineutrophil cytoplasmic antibody-associated vasculitis.